Trade BIOHAVEN ORD - BHVN CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.1
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021651 %(-$0.43)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.02165%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000571 %(-$0.01)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.00057%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021651 %
  (-$0.43)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000571 %
  (-$0.01)

Key Stats

• Prev. Close: 15.21
• Open: 15.16
• 1-Year Change: -0.92%
• Day's Range: 14.96 - 15.74

Trade BIOHAVEN ORD - BHVN

What is BIOHAVEN ORD (BHVN)?

Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company focused on the development and commercialization of therapies for neurological diseases. The company specializes in innovative treatments targeting conditions such as migraine, neurodegenerative diseases, and rare neurological disorders. Biohaven's research and development efforts emphasize the discovery of novel mechanisms of action to address unmet medical needs. The company operates through a combination of in-house research and strategic collaborations to advance its pipeline. Biohaven's portfolio includes both small molecule drugs and biologics, aiming to improve patient outcomes in complex neurological conditions. The company is headquartered in the United States and engages in clinical trials to evaluate the safety and efficacy of its product candidates. Biohaven's approach integrates scientific research with clinical development to bring new therapeutic options to the market. It is recognized for its contributions to the field of neurology and its commitment to advancing treatment options for patients worldwide.

BIOHAVEN ORD Stock Price Today: Live Overview

The price today is shaped by active market conditions, with BLACKROCK THROGMORTON TRUST PLC priced at $15.83. The session’s trading range lies between $14.84 and $15.82, showing a daily change of +2.9178%.

FAQ: BIOHAVEN ORD (BHVN)

What is the current price of BHVN stock?

The last recorded price is $15.83.

Does BHVN pay dividends?

BIOHAVEN ORD pays dividends to its shareholders.

Does BHVN have a formal corporate presence or regional headquarters in the UAE?

BIOHAVEN ORD operates in the UAE exclusively via partners and distributors.

What is BHVN best known for?

BIOHAVEN ORD is most famous for its development of neurological and neuropsychiatric therapies.

What assets are typically shown together with BHVN?

Commonly shown alongside BHVN: Future PLC, Invesco S&P 500 Revenue ETF, Amprius Technologies Inc